ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

STX Shield Therapeutics Plc

2.85
-0.10 (-3.39%)
22 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -3.39% 2.85 2.80 2.90 2.95 2.85 2.90 2,684,036 08:23:30
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 13.09M -33.29M -0.0429 -0.66 22.88M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 2.95p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 7.65p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £22.88 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.66.

Shield Therapeutics Share Discussion Threads

Showing 21051 to 21071 of 21500 messages
Chat Pages: Latest  848  847  846  845  844  843  842  841  840  839  838  837  Older
DateSubjectAuthorDiscuss
29/10/2024
10:10
I think £1 million was not paid until 30th sept and Canada has not started yet. So £0.8 milion inclueds Europe and 250k from Canada approval.
krp10
29/10/2024
10:07
a couple of things do not make sense
net sell revenue from US is 7.2m, they also have milestone of 1m, so don't understand why the total is 8m, or this has not been paid so not take into consideration? Also, what is the revenue from other countries?
I feel the number is not reflecting the complete picture, the total revenue should be higher.

qipincha
29/10/2024
10:06
I repeat listen to PATT at your peril.
parob
29/10/2024
09:53
Actually it just depends on revenues.Go look at other iron drugs and tell me why this one will be different.Although, I do recognise their battle is getting into a generics dominated market, which isn't easy.But it's doable with persistence and skill. Agree they've lacked some skill.I'm disappointed with this quarter but it doesn't mean the games up especially while AOP are all in
skcots48
29/10/2024
09:51
I understand issues with previous head.
But it is not the case now.
If the business model has an issue, AOP will simply not invest in the company

qipincha
29/10/2024
09:50
That is a ridiculous reaction to continued growth, sorting out funding, reducing costs snd repeating cash burn ends close of 2025 with Rx continuing to rise.
purchaseatthetop
29/10/2024
09:28
This business model was destroyed years ago, I don’t see it coming back, tens of millions will be needed, more and more dilution.

Blame the previous reckless management, mugs just buying dead cat bounces.

ny boy
29/10/2024
09:19
No panic. This is manipulation by those who want to hoover up cheap shares
wheeze
29/10/2024
09:00
Not sure why panic
As far as I can see all heading to the right direction
Extra funding is to ensure growing plan
And funding is supported by AOP not us
To make profit at the end of 2025 is a target not too far now

qipincha
29/10/2024
08:54
Bones. You should have posted that on on POLX
purchaseatthetop
29/10/2024
08:45
Generally no. But where PATT is concerned yes. Witnessed it over the last few years.His arrogance is off the scale.
parob
29/10/2024
08:41
Oh dear sales slowing and heading south In a hurry after the update disappointed . Hard to see a future decent business here .
bones698
29/10/2024
08:30
Firstly, apologies Skots, I didn't and frankly still don't understand wholesalers stocking up in July. They managed to hit the neutral point, near enough hitting exactly what I thought in terms of count, but £500k shy on revenue. 4p will be a bit of an anchor both ways - buying under is something of a free hit.
hpcg
29/10/2024
08:25
So you believe in jinxes parrot?
zeus19
29/10/2024
08:25
Boiler room boys in panic mode Heading below 1p Get out whilst you can Leaking sinking boat
hamidahamida
29/10/2024
08:25
Yep another share that PATT has jinxed.He does what his avatar says, buys at the top and then the shares tend to dive. If he buys in, best to get out imo.I have been saying this but have been called out for it.
parob
29/10/2024
08:18
Agree base. Director buying would make a statement.
purchaseatthetop
29/10/2024
08:17
Funding at 4p is certainly better than & takeover by AOP at 2.5p & we are still in the game.Disappointing that there has been clearly large volume selling ahead of the 4p raise ,yet again - which is a disgrace-& illegal- not the Regulators will take action.
$11.5mill revenue in Q4 is positive as it infers FY25 revenues of over $50mill-assuming we achieve modest quarterly growth in FY25 + revenues from Canada should start along with South Korea ( hopefully )
Could have been much worse & lets see what Batman & Robin have to say on Thursday & whether they will back up their expected confidence with actual share buying.

base7
29/10/2024
08:16
Another Richard Bobath clanger .. best contra indicator in the market when that conman buys in
dplewis1
29/10/2024
08:13
A long and troubling road ahead with lots of cash raises. let’s see what mr Market makes of all this fluffy rns
ny boy
29/10/2024
08:04
All looks perfectly reasonable and meeting broker forecasts which also suggest a muchhigher fair value. Brainless trashing comments have a clear motivation.
photon
Chat Pages: Latest  848  847  846  845  844  843  842  841  840  839  838  837  Older

Your Recent History

Delayed Upgrade Clock